Memantine is available for purchase as a prescription medication used to treat moderate to severe Alzheimer's disease [1]. It is also marketed under the brand name Namenda [2].
What is Memantine prescribed for?
Memantine is prescribed to treat patients experiencing moderate to severe dementia associated with Alzheimer's disease [1]. It works by regulating the activity of glutamate, a neurotransmitter in the brain [3].
How does Memantine work in Alzheimer's disease?
Alzheimer's disease can lead to an overstimulation of the brain's glutamate receptors, which can result in nerve cell damage. Memantine is an NMDA receptor antagonist that works by blocking excessive glutamate activity, thereby protecting brain cells from damage and improving cognitive function [3].
What are the available forms of Memantine?
Memantine is available in several formulations, including immediate-release tablets, extended-release capsules, and oral solutions [1].
What is the brand name for Memantine?
The most common brand name for memantine in the United States is Namenda [2].
When does the patent for Memantine expire?
Information regarding the specific patent expiration dates for memantine and its brand-name formulations can be found on specialized drug patent tracking websites. These sites often provide detailed timelines for patent and exclusivity periods, which are crucial for understanding when generic versions may become available [4]. For example, DrugPatentWatch.com offers comprehensive data on drug patents and their expiration [4].
Can I buy Memantine over-the-counter?
No, memantine is a prescription-only medication and cannot be purchased over-the-counter [1]. A valid prescription from a healthcare provider is required.
What are the potential side effects of Memantine?
Common side effects of memantine may include dizziness, headache, constipation, confusion, and drowsiness [1]. Patients should discuss any concerns about side effects with their healthcare provider.
Are there generic versions of Memantine available?
The availability of generic versions of memantine depends on patent expirations. Once patents expire and regulatory approvals are granted, generic manufacturers can produce and sell their versions of the drug, often at a lower cost [4].
How does Memantine compare to other Alzheimer's medications?
Memantine targets a different mechanism than other Alzheimer's medications, such as cholinesterase inhibitors (e.g., donepezil, rivastigmine, galantamine). While cholinesterase inhibitors increase levels of acetylcholine, memantine modulates glutamate activity. These medications may be used alone or in combination to manage symptoms of Alzheimer's disease [3].
---
1. "Memantine." MedlinePlus, U.S. National Library of Medicine, https://medlineplus.gov/druginfo/meds/a606012.html.
2. "Namenda." Drugs.com, https://www.drugs.com/namenda.html.
3. "Memantine Hydrochloride." National Institute on Aging, U.S. Department of Health and Human Services, https://www.nia.nih.gov/health/alzheimers-disease-medications/memantine-hydrochloride.
4. "Drug Patent Watch." DrugPatentWatch.com, https://drugpatentwatch.com/.